SHE:002262 Market Cap

SHE:002262 has a market cap or net worth of 19.66 billion as of June 29, 2026. Its market cap has decreased by -16.30% in one year.

Market Cap

19.66B

Enterprise Value

15.59B

Revenue

6.01B

Ranking

n/a

PE Ratio

18.24

Stock Price

19.35

Market Cap Chart

Since July 23, 2008, SHE:002262's market cap has increased from 1.26B to 19.66B, an increase of 1,454.41%. That is a compound annual growth rate of 16.52%.

Market Cap History

Date	Market Cap	% Change
Jun 29, 2026	19.66B	-19.81%
Dec 31, 2025	24.51B	-0.94%
Dec 31, 2024	24.74B	-9.45%
Dec 29, 2023	27.33B	10.47%
Dec 30, 2022	24.74B	56.87%
Dec 31, 2021	15.77B	-2.01%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jilin Aodong Pharmaceutical Group	20.56B
Tasly Pharmaceutical Group	19.78B
Guangdong Zhongsheng Pharmaceutical	19.20B
Shanghai Haoyuan Chemexpress	19.12B
Walvax Biotechnology	18.66B
Chengdu Kanghong Pharmaceutical Group	17.98B
Apeloa Pharmaceutical Co.,Ltd	17.97B
Hybio Pharmaceutical	17.46B

Market Cap Rankings